from april 26 to 27, 2019, the 9th china drug quality and safety conference sponsored by the center for the development and supervision of food and drug industry, chinese academy of social sciences, was successfully held in kaiyuan hotel, zhejiang pr
in recent years, biopharmaceuticals have achieved great success in the fields of chronic diseases, cancer and autoimmune diseases with the characteristics of high targeting and safety. they have attracted worldwide attention and become the star of th
recalling that in 2018, with the rapid development of china's pharmaceutical industry, drug supervision is also continuing. according to incomplete statistics, 51 enterprises have been withdrawn gmp certificates due to various quality problems. it is
2019 (4th) ebc was held in nanjing on march 2-3. the conference was sponsored by yimao medical and co-sponsored by many trade associations. more than 1500 outstanding representatives from scientific research, industrial and medical fields participate
on january 5, 2019, organized by alite life sciences and co-sponsored by biological products circle as a media platform, the "upstream technology exchange of antibody drugs 2019" went on smoothly in sheraton fuzhou fupeng hotel, and there were no sea
clean up and pay attention to it immediately